Contact Support +1-(281)-619-8646
Active Pharmaceutical Ingredients Market Overview
An overview of conceptual frameworks, analytical approaches of the active pharmaceutical ingredients market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. The active pharmaceutical ingredients market is expected to grow at a significant rate in the near future.
The global active pharmaceutical ingredients market is estimated to reach at a value of US$ 184.7 Bn by the end of 2020 and expected to reach at a value of US$ 309.8 Bn by 2028 with a significant CAGR of 6.7%.
Active Pharmaceutical Ingredients Market Definition
The active pharmaceutical ingredients can be referred to as any biologically or chemically active component or combination of components utilized in a complete pharmaceutical product, which aims to fix up pharmacological action or contrarily to have immediate effect in the diagnosis, healing, alleviation, medical care or prevention of illness, or to have immediate effect in rectifying, restoring, or modifying physiological functions in human beings.
For most of the time, the active pharmaceutical ingredients (APIs) are produced by the pharmaceutical companies only in their respective countries. Although in recent years, the majority of pharmaceutical corporations have preferred to export manufacturing in foreign countries in order to cut off expenses. This has paved the way to essential modifications in the way these drugs are regulated, with more strict guidelines and checks in location.
Active Pharmaceutical Ingredients Market Dynamics
The constantly increasing number of research and development activities associated with drugs and medicines across the world is majorly boosting the growth of the global active pharmaceutical ingredients market.
In the last few decades, the number of healthcare activities as well as usage of drugs, medicines and biologics in treating patients, worldwide, has also increased tremendously, which further projected to propel the growth of the global active pharmaceutical ingredient market over the forecast period.
By the same token, the healthcare infrastructure has also been revolutionized in the past few decades, which has escalated the healthcare spending enormously. The increased focus on healthcare spending in recent years has also positively influenced the growth of the global active pharmaceutical ingredients market.
Moreover, the emerging trend of shipping or outsourcing R&D activities and manufacturing processes in foraging countries for the purpose of eliminating additional expenses and costs as well as better operational efficiency has also played a positive role in supporting the growth of the global active pharmaceutical ingredients market.
In addition, the rising trend of precision or specialty medicines all across the world is also estimated to give a number of breakthroughs to the growth of the global active pharmaceutical ingredients market in the given timeframe.
Furthermore, the constantly soaring number of chronic ailments among the population and various technological advancements in API manufacturing is also augmenting the growth of the global active pharmaceutical ingredients market.
In the present-day world, the global market is also witnessing huge implementation of artificial intelligence-based drug discovery instruments and techniques which further accelerates the growth of the global active pharmaceutical ingredients market.
However, the intense rivalry between the leading API manufacturers as well as increasing development of anti-counterfeit drugs is likely to restrain the growth of the global active pharmaceutical ingredients market in the coming years.
Active Pharmaceutical Ingredients Market Segmentation
The global active pharmaceutical ingredients market is segmented on the basis of type, type of manufacturer, type of synthesis, type of drug, therapeutic application, and region.
On the basis of the type, the active pharmaceutical ingredients market is segmented into Innovative Active Pharmaceutical Ingredients and Generic Active Pharmaceutical Ingredients.
On the basis of type of manufacturer active pharmaceutical ingredients market segment is divided into Captive API Manufacturers, Merchant API Manufacturers.
Further, On the basis of type of synthesis segment is divided into Synthetic Active Pharmaceutical Ingredients and Biotech Active Pharmaceutical Ingredients.
On the basis of type of drug segment is bifurcated into Prescription Drugs, Over-The-Counter Drugs.
Furthermore, on the basis of therapeutic application active pharmaceutical ingredients market segmented into Communicable Diseases, Oncology, Pain Management, Cardiovascular Diseases, Diabetes, Respiratory Diseases, and Other Therapeutic Applications.
Active Pharmaceutical Ingredients Market Key Players
The global active pharmaceutical ingredients market is dominated by Pfizer Inc., Novartis AG, Sanofi, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company., GlaxoSmithKline plc., Merck Sharp & Dohme Corp., AbbVie Inc., AstraZeneca, Aurobindo Pharma, BASF SE, Dr. Reddy’s Laboratories Ltd., LUPIN., Mylan N.V., Sun Pharmaceutical Industries Ltd, Piramal Pharma Solutions, Sandoz International GmbH, Saneca Pharmaceuticals and others.
Active Pharmaceutical Ingredients Market Regional Overview and Analysis
At present, North America monopolizes the global active pharmaceutical ingredients market and is projected to carry on its citadel for a couple more years. All the more, this region is estimated to elevate its market share in the forthcoming future, due to the growing incidences of disease and increasing geriatric population.
Currently, the largest share of the market in North America is with the United States. On the other hand, most of the API requirements are fulfilled through imports from the Asian Markets.
In addition, according to the US trade statistics, around 75% to 80% of the APIs shipped to the United States are from India and China, as these nations have deep-rooted manufacturing facilities and a plenty of manpower resources providing its services to the pharmaceutical sector.
Furthermore, the latest trade and political policies enforced by the US government to escalate import taxes and duties are further projected to propel operational costs and boost the pricing pressure on the manufacturers.
Noticeably, the FDA has also advanced the application fees for new drug approvals and has also elevated the number of regular inspections conducted on several different off-shore contract manufacturing services to make certain the yield of superior-quality products to the United States market.
MMC Overview on Active Pharmaceutical Ingredients Market Report
The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give a better opportunity for the customers to put their effort.
A research report on the Active Pharmaceutical Ingredients market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that support the market and the factors that are acting as impedance for the growth of the market.
Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market. The report is titled as ‘Active Pharmaceutical Ingredients Market: Opportunity Analysis and Future Assessment 2020-2028’.
Factors that are benchmarked while estimating the market
Various factors that are benchmarked while estimating the market growth includes (but not restricted to):
New product designs and launches
Current product compliance
Reimbursement
Concerns for use of Active Pharmaceutical Ingredients
Advantages of Active Pharmaceutical Ingredients
Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to make informed decisions.
A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.
1. Global Active Nutraceutical Ingredients Market Report Overview
1.1. Introduction
1.2. Report Description
1.3. Methodology
2. Global Active Nutraceutical Ingredients Market Overview
2.1. Introduction
2.1.1. Market Definition
2.1.2. Market Taxonomy
2.2. Executive Summary
2.3. Global Active Nutraceutical Ingredients Market Snapshot
2.4. Global Active Nutraceutical Ingredients Market Size and Forecast, 2020–2028
2.4.1. Introduction
2.4.2. Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)
2.5. Global Active Nutraceutical Ingredients Market Dynamics
2.5.1. Drivers
2.5.2. Restraints
2.5.3. Opportunity
2.5.4. Trends
2.6. Key Regulations
2.7. Porter’s Five Forces Model
3. Global Active Nutraceutical Ingredients Market, By Ingredient Type
3.1. Introduction
3.1.1. Annual Growth Rate Comparison, By Ingredient Type
3.1.2. BPS Analysis, By Ingredient Type
3.2. Market Revenue (US$Mn) and Volume (KT) Forecast, By Ingredient Type
3.2.1. Prebiotic
3.2.2. Probiotic
3.2.3. Proteins
3.2.4. Vitamins
3.2.5. Minerals
3.2.6. OMEGA 3 Structured Lipids
3.2.7. Phytochemicals & Plant Extracts
3.2.8. Fibers and Specialty Carbohydrates
3.3. Global Active Nutraceutical Ingredients Market Attractiveness Index, By Ingredient Type
4. Global Active Nutraceutical Ingredients Market, By Application
4.1. Introduction
4.1.1. Annual Growth Rate Comparison, By Application
4.1.2. BPS Analysis, By Application
4.2. Market Revenue (US$Mn) and Volume (KT) Forecast, By Application
4.2.1. Functional Foods
4.2.2. Functional Beverages
4.2.3. Dietary Supplements
4.2.4. Animal Nutrition
4.2.5. Cosmetics
4.2.6. Baby Products
4.2.7. Others
4.3. Global Active Nutraceutical Ingredients Market Attractiveness Index, By Application
5. Global Active Nutraceutical Ingredients Market, By Region
5.1. Introduction
5.1.1. Annual Growth Rate Comparison, By Region
5.1.2. BPS Analysis, By Region
5.2. Market Revenue (US$Mn) and Volume (KT) Forecast, By Region
5.2.1. North America
5.2.2. Latin America
5.2.3. Europe
5.2.4. Asia Pacific
5.2.5. Middle East
5.2.6. Africa
5.3. Global Active Nutraceutical Ingredients Market Attractiveness Index, By Region
6. North America Active Nutraceutical Ingredients Market Analysis and Forecast, 2020–2028
6.1. Introduction
6.1.1. Annual Growth Rate Comparison, By Country
6.1.2. BPS Analysis, By Country
6.2. Market Revenue (US$Mn) and Volume (KT) Forecast, By Country
6.2.1. U.S. Active Nutraceutical Ingredients Market
6.2.2. Canada Active Nutraceutical Ingredients Market
6.3. North America Active Nutraceutical Ingredients Market, By Ingredient Type
6.3.1. Prebiotic
6.3.2. Probiotic
6.3.3. Proteins
6.3.4. Vitamins
6.3.5. Minerals
6.3.6. OMEGA 3 Structured Lipids
6.3.7. Phytochemicals & Plant Extracts
6.3.8. Fibers and specialty Carbohydrates
6.4. North America Active Nutraceutical Ingredients Market, By Application
6.4.1. Functional Foods
6.4.2. Functional Beverages
6.4.3. Dietary Supplements
6.4.4. Animal Nutrition
6.4.5. Cosmetics
6.4.6. Baby Products
6.4.7. Others
6.5. North America Active Nutraceutical Ingredients Market Attractiveness Index
6.5.1. By Country
6.5.2. By Ingredient Type
6.5.3. By Application
7. Latin America Active Nutraceutical Ingredients Market Analysis and Forecast, 2020–2028
7.1. Introduction
7.1.1. Annual Growth Rate Comparison, By Country
7.1.2. BPS Analysis, By Country
7.2. Market Revenue (US$Mn) and Volume (KT) Forecast, By Country
7.2.1. Brazil Active Nutraceutical Ingredients Market
7.2.2. Mexico Active Nutraceutical Ingredients Market
7.2.3. Argentina Active Nutraceutical Ingredients Market
7.2.4. Rest of Latin America Active Nutraceutical Ingredients Market
7.3. Latin America Active Nutraceutical Ingredients Market, By Ingredient Type
7.3.1. Prebiotic
7.3.2. Probiotic
7.3.3. Proteins
7.3.4. Vitamins
7.3.5. Minerals
7.3.6. OMEGA 3 Structured Lipids
7.3.7. Phytochemicals & Plant Extracts
7.3.8. Fibers and specialty Carbohydrates
7.4. Latin America Active Nutraceutical Ingredients Market, By Application
7.4.1. Functional Foods
7.4.2. Functional Beverages
7.4.3. Dietary Supplements
7.4.4. Animal Nutrition
7.4.5. Cosmetics
7.4.6. Baby Products
7.4.7. Others
7.5. Latin America Active Nutraceutical Ingredients Market Attractiveness Index
7.5.1. By Country
7.5.2. By Ingredient Type
7.5.3. By Application
8. Europe Active Nutraceutical Ingredients Market Analysis and Forecast, 2020–2028
8.1. Introduction
8.1.1. Annual Growth Rate Comparison, By Country
8.1.2. BPS Analysis, By Country
8.2. Market Revenue (US$Mn) and Volume (KT) Forecast, By Country
8.2.1. U.K. Active Nutraceutical Ingredients Market
8.2.2. Germany Active Nutraceutical Ingredients Market
8.2.3. Italy Active Nutraceutical Ingredients Market
8.2.4. France Active Nutraceutical Ingredients Market
8.2.5. Spain Active Nutraceutical Ingredients Market
8.2.6. Russia Active Nutraceutical Ingredients Market
8.2.7. Poland Active Nutraceutical Ingredients Market
8.2.8. BENELUX Active Nutraceutical Ingredients Market
8.2.9. NORDIC Active Nutraceutical Ingredients Market
8.2.10. Rest of Europe Active Nutraceutical Ingredients Market
8.3. Europe Active Nutraceutical Ingredients Market, By Ingredient Type
8.3.1. Prebiotic
8.3.2. Probiotic
8.3.3. Proteins
8.3.4. Vitamins
8.3.5. Minerals
8.3.6. OMEGA 3 Structured Lipids
8.3.7. Phytochemicals & Plant Extracts
8.3.8. Fibers and specialty Carbohydrates
8.4. Europe Active Nutraceutical Ingredients Market, By Application
8.4.1. Functional Foods
8.4.2. Functional Beverages
8.4.3. Dietary Supplements
8.4.4. Animal Nutrition
8.4.5. Cosmetics
8.4.6. Baby Products
8.4.7. Others
8.5. Europe Active Nutraceutical Ingredients Market Attractiveness Index
8.5.1. By Country
8.5.2. By Ingredient Type
8.5.3. By Application
9. Asia Pacific Active Nutraceutical Ingredients Market Analysis and Forecast, 2020–2028
9.1. Introduction
9.1.1. Annual Growth Rate Comparison, By Country
9.1.2. BPS Analysis, By Country
9.2. Market Revenue (US$Mn) and Volume (KT) Forecast, By Country
9.2.1. China Active Nutraceutical Ingredients Market
9.2.2. India Active Nutraceutical Ingredients Market
9.2.3. Japan Active Nutraceutical Ingredients Market
9.2.4. Australia And New Zealand Active Nutraceutical Ingredients Market
9.2.5. South Korea Active Nutraceutical Ingredients Market
9.2.6. ASEAN Active Nutraceutical Ingredients Market
9.2.7. Rest of Asia Pacific Active Nutraceutical Ingredients Market
9.3. Asia Pacific Active Nutraceutical Ingredients Market, By Ingredient Type
9.3.1. Prebiotic
9.3.2. Probiotic
9.3.3. Proteins
9.3.4. Vitamins
9.3.5. Minerals
9.3.6. OMEGA 3 Structured Lipids
9.3.7. Phytochemicals & Plant Extracts
9.3.8. Fibers and specialty Carbohydrates
9.4. Asia Pacific Active Nutraceutical Ingredients Market, By Application
9.4.1. Functional Foods
9.4.2. Functional Beverages
9.4.3. Dietary Supplements
9.4.4. Animal Nutrition
9.4.5. Cosmetics
9.4.6. Baby Products
9.4.7. Others
9.5. Asia Pacific Active Nutraceutical Ingredients Market Attractiveness Index
9.5.1. By Country
9.5.2. By Ingredient Type
9.5.3. By Application
10. Middle East Active Nutraceutical Ingredients Market, By Region
10.1. Introduction
10.1.1. Annual Growth Rate Comparison, By Country
10.1.2. BPS Analysis, By Country
10.2. Market Revenue (US$Mn) and Volume (KT) Forecast, By Country
10.2.1. GCC Countries Active Nutraceutical Ingredients Market
10.2.2. Israel Active Nutraceutical Ingredients Market
10.2.3. Oman Active Nutraceutical Ingredients Market
10.2.4. Rest of Middle East Active Nutraceutical Ingredients Market
10.3. Middle East Active Nutraceutical Ingredients Market, By Ingredient Type
10.3.1. Prebiotic
10.3.2. Probiotic
10.3.3. Proteins
10.3.4. Vitamins
10.3.5. Minerals
10.3.6. OMEGA 3 Structured Lipids
10.3.7. Phytochemicals & Plant Extracts
10.3.8. Fibers and specialty Carbohydrates
10.4. Middle East Active Nutraceutical Ingredients Market, By Application
10.4.1. Functional Foods
10.4.2. Functional Beverages
10.4.3. Dietary Supplements
10.4.4. Animal Nutrition
10.4.5. Cosmetics
10.4.6. Baby Products
10.4.7. Others
10.5. Middle East Active Nutraceutical Ingredients Market Attractiveness Index
10.5.1. By Country
10.5.2. By Ingredient Type
10.5.3. By Application
11. Africa Active Nutraceutical Ingredients Market, By Region
11.1. Introduction
11.1.1. Annual Growth Rate Comparison, By Country
11.1.2. BPS Analysis, By Country
11.2. Market Revenue (US$Mn) and Volume (KT) Forecast, By Country
11.2.1. South Africa Active Nutraceutical Ingredients Market
11.2.2. Egypt Active Nutraceutical Ingredients Market
11.2.3. North Africa Active Nutraceutical Ingredients Market
11.2.4. Rest of Africa Active Nutraceutical Ingredients Market
11.3. Africa Active Nutraceutical Ingredients Market, By Ingredient Type
11.3.1. Prebiotic
11.3.2. Probiotic
11.3.3. Proteins
11.3.4. Vitamins
11.3.5. Minerals
11.3.6. OMEGA 3 Structured Lipids
11.3.7. Phytochemicals & Plant Extracts
11.3.8. Fibers and specialty Carbohydrates
11.4. Africa Active Nutraceutical Ingredients Market, By Application
11.4.1. Functional Foods
11.4.2. Functional Beverages
11.4.3. Dietary Supplements
11.4.4. Animal Nutrition
11.4.5. Cosmetics
11.4.6. Baby Products
11.4.7. Others
11.5. Africa Active Nutraceutical Ingredients Market Attractiveness Index
11.5.1. By Country
11.5.2. By Ingredient Type
11.5.3. By Application
12. Recommendation
12.1. Market Strategy
13. Competitive Landscape
13.1. Competition Dashboard
13.2. List and Company Overview of Global Key Players
13.3. Company Profiles
13.3.1. Cargill, Incorporated
13.3.1.1. Company Overview
13.3.1.2. Financial Overview
13.3.1.3. Product Portfolio
13.3.1.4. Key Developments
13.3.1.5. Business Strategies
13.3.2. E. I. Du Pont De Nemours and Company
13.3.3. BASF SE
13.3.4. Archer Daniels Midland Company
13.3.5. Associated British Foods PLC
13.3.6. Ajinomoto Co.
14. Acronyms
